Published November, 2011
By H. Koprowski, P. Koldovsky, W. Arber, R. Haas, E. Wecker, W. Henle, W. Braun, P. H. Hofschneider, N. K. Jerne, O. Maaløe, R. Rott, H. G. Schweiger, M. Sela, L. Svru?ek, P. K. Vogt, J. H. Humphrey, F. Cramer and O. Maaloe
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Current Topics in Microbiology and Immunology
Rating:
Availability: Available

Two kinds of antigenic variation occur in influenza viruses, antigenic drift and major antigenic shifts; Antigenic drift, which involves gradual changes in the surface antigens of influenza virus, is thought to result from the selection by an immune popula tion of mutant virus particles with altered antigenic determinants.

---

Published November, 2011
By H. Koprowski, F. Melchers, P. Koldovsky, W. Arber, R. Haas, W. Henle, W. Braun, J. Klein, P. H. Hofschneider, N. K. Jerne, O. Maaløe, R. Rott, H. G. Schweiger, P. K. Vogt, L. Syru?ek, J. H. Humphrey, S. Falkow, F. Cramer and O. Maaloe
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Current Topics in Microbiology and Immunology
Rating:
Availability: Available

The difference in agglutinin titre between High and Low lines is 220-fold in Selection I, 103-fold in Selection II, 90-fold in Selection III, 85-fold in Selection IV and 275-fold in Selection V.

---

Published November, 2011
By H. Koprowski, F. Melchers, P. Koldovsky, W. Arber, R. Haas, W. Henle, W. Braun, J. Klein, P. H. Hofschneider, N. K. Jerne, O. Maaløe, R. Rott, H. G. Schweiger, P. K. Vogt, L. Syru?ek, J. H. Humphrey, S. Falkow, F. Cramer and O. Maaloe
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Current Topics in Microbiology and Immunology
Rating:
Availability: Available

1.2 Definition of Defective Interfering (DI) Particles Defective interfering viral particles, as defined by Huang (1973), have the follow ing properties: (1) they are deletion mutants and therefore lack large amounts of the genetic material present in the standard virus;

---

Published November, 2011
By H. Koprowski, F. Melchers, P. Koldovsky, W. Arber, R. Haas, W. Henle, W. Braun, J. Klein, P. H. Hofschneider, N. K. Jerne, O. Maaløe, R. Rott, H. G. Schweiger, P. K. Vogt, L. Syru?ek, J. H. Humphrey, J. H. Humprey, F. Cramer and O. Maaloe
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Current Topics in Microbiology and Immunology
Rating:
Availability: Available

---

Published November, 2011
By H. Koprowski, F. Melchers, P. Koldovsky, W. Arber, R. Haas, W. Henle, W. Braun, J. Klein, P. H. Hofschneider, N. K. Jerne, O. Maaløe, R. Rott, H. G. Schweiger, P. K. Vogt, L. Syru?ek, J. H. Humphrey, F. Cramer and O. Maaloe
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Current Topics in Microbiology and Immunology
Rating:
Availability: Available

---

Published November, 2011
By Peter Pietschmann
Publisher: Springer (Springer Verlag GmbH)
Rating:
Availability: Contact supplier

Osteoimmunology is a developing field of great importance. This book describes the basics of bone biology and of the immune system. It provides insight into the molecular mechanisms of bone diseases, and clinical data are presented and set in context.

---

Published November, 2011
By J.V. Bannister
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Proceedings in Life Sciences
Rating:
Availability: Available

---

Published November, 2011
By A.C. Allison
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Handbook of Experimental Pharmacology
Rating:
Availability: Available

With contributions by numerous experts

---

Published November, 2011
By Michael R. McGinnis
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Current Topics in Medical Mycology
Rating:
Availability: Available

---

Published November, 2011
By Michel Chofflon and Lawrence Steinman
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

This knowledge about modifications in the pathways of neuroimmune diseases has enabled the development of new therapies. In this volume leading experts present the state of the art in the field, covering all aspects from basic science to the development of better therapies.

---